Osborne Clarke in Belgium has advised Sunrise, a healthtech company founded in 2015 in Belgium, on its €3.25 million fundraising round. Led by Kurma Partners, this round of financing, in which the Vives-IUF fund linked to UCLouvain and Namur Invest also participated, has the objective of launching and internationally marketing the company's first diagnostic product for sleep apnea.
In addition to this €3.25 million round of funding, there is also €3.25 million in non-dilutive funding from the European Innovation Council, launched in 2021 by the European Commission to transform scientific ideas into promising innovations, and the Walloon Region.
Founded in 2015 by Laurent and Pierre Martinot, Sunrise aims to democratize access to care for sleep apnea syndrome. This serious respiratory disorder is known for multiplying mortality risk by factor 3. The Sunrise innovation is based on more than ten years of research : the technology detects respiratory events based on the analysis of the respiratory drive (which is reflected in the contractions of the respiratory muscles and the movements these cause at the level of the chin). In 2021, it gained an award at the CES in Las Vegas. Currently, about twenty people (located in Belgium and France) work for Sunrise, a scale-up that aims to market its medical device in the United States and France.
The Osborne Clarke team was composed of Laurent De Pauw, Olivier Lambillon, Valentin de le Court, Benjamin Docquir and Marie Canivet and led by Partner Hadrien Chef.
Osborne Clarke has a market-leading international venture capital practice and is widely recognized as a leading European law firm for companies operating in the life science and healthcare sector. The Venture Capital team is ranked tier one by the Legal 500 and has experts across Europe and in the UK. It has an outstanding track record advising start-ups, global market leaders, angel investors and institutional VC/growth capital investors on funding rounds, follow-on rounds, venture debt facilities, IPOs, trade sales and buy & build projects.
Corporate communications and press contacts
Connect with one of our experts
